Successful EU support: MobilAlarm device available at the market

empiricaAs of May 2007, the mobile emergency device that was tested in the international project MobilAlarm will be marketed. empirica co-ordinated this project from April 2004 to August 2005. The European Commission supported MobilAlarm in the framework of its programme eTEN electronic Trans-European Networks.

Thus, MobilAlarm is an example of how the European Commission can help innovative product and service ideas to the market. Initially, the device will be offered in Germany, Switzerland, the Netherlands, the United Kingdom, and Slovakia. In Germany, the Vitaris company (www.vitaris-gmbh.de), previously named Attendo Systems and main industry partner in the MobilAlarm project, offers the device as "Vitaris Mobile".

About empirica
empirica has many years of experience in quantitative and qualitative research methods. Its clients are private companies and public bodies: large and medium-sized companies in the insurance, pharmaceutical and automobile industries as well as software developers and hardware manufacturers. There are also telecommunications service companies and network providers, social services firms, medical facilities, Federal and State Government ministries in Germany and the European Commission as well as the European statistical office (Eurostat). For further information, please visit www.empirica.com

About MobilAlarm project
European MobilAlarm project tested an innovative, location-independent alarm service which enables older people, those concerned about safety, the chronically ill, and the disabled to initiate an alarm call whenever and wherever they need or want to do so, thus improving their quality of life. For further information, please visit www.mobilalarm-eu.org

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...